OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
Heng‐Chung Kung, Jun Yu
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 24
Heng‐Chung Kung, Jun Yu
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 24
Showing 24 citing articles:
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 66
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 66
Recent advances in drug delivery and targeting for the treatment of pancreatic cancer
Nilkamal Pramanik, Aditya K. Gupta, Yashwardhan Ghanwatkar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 231-260
Closed Access | Times Cited: 13
Nilkamal Pramanik, Aditya K. Gupta, Yashwardhan Ghanwatkar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 231-260
Closed Access | Times Cited: 13
Dynamic Immunoediting by Macrophages in Homologous Recombination Deficiency-Stratified Pancreatic Ductal Adenocarcinoma
Weifeng Hong, Feng Zhang, Nan Wang, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101115-101115
Closed Access | Times Cited: 4
Weifeng Hong, Feng Zhang, Nan Wang, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101115-101115
Closed Access | Times Cited: 4
Borax Pentahydrate as a Promising Boron-Based Angiogenesis Inhibitor
Gönül Ulus, Emine Nur ÖZBEK, Hamza Yılmaz, et al.
Journal of Trace Elements in Medicine and Biology (2025) Vol. 89, pp. 127640-127640
Closed Access
Gönül Ulus, Emine Nur ÖZBEK, Hamza Yılmaz, et al.
Journal of Trace Elements in Medicine and Biology (2025) Vol. 89, pp. 127640-127640
Closed Access
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitumor and safety profile
Camilla Pecoraro, Daniela Carbone, Fabio Scianò, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 10, pp. 1278-1294
Open Access | Times Cited: 3
Camilla Pecoraro, Daniela Carbone, Fabio Scianò, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 10, pp. 1278-1294
Open Access | Times Cited: 3
Single-cell omics: a new perspective for early detection of pancreatic cancer?
Wang Qi, Berina Šabanović, Azhar Awada, et al.
European Journal of Cancer (2023) Vol. 190, pp. 112940-112940
Closed Access | Times Cited: 7
Wang Qi, Berina Šabanović, Azhar Awada, et al.
European Journal of Cancer (2023) Vol. 190, pp. 112940-112940
Closed Access | Times Cited: 7
Advancing Cancer Treatment Through Nanotechnology Driven Immunotherapy for Pancreatic Cancer
Sreejith Thrivikraman Nair, Kaladhar Kamalasanan, Smarakan Sneha, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 20, pp. 18670-18697
Closed Access | Times Cited: 7
Sreejith Thrivikraman Nair, Kaladhar Kamalasanan, Smarakan Sneha, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 20, pp. 18670-18697
Closed Access | Times Cited: 7
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: Synthesis, mechanistic Insights and promising antitumor and safety profile
Daniela Carbone, Camilla Pecoraro, Fabio Scianò, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Daniela Carbone, Camilla Pecoraro, Fabio Scianò, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Targeted Therapies in Pancreatic Cancer: A New Era of Precision Medicine
Bingyu Li, Qiong Zhang, Claire Castaneda, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2175-2175
Open Access | Times Cited: 2
Bingyu Li, Qiong Zhang, Claire Castaneda, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2175-2175
Open Access | Times Cited: 2
Targeting Ras with protein engineering
Atílio Tomazini, Julia M. Shifman
Oncotarget (2023) Vol. 14, Iss. 1, pp. 672-687
Open Access | Times Cited: 5
Atílio Tomazini, Julia M. Shifman
Oncotarget (2023) Vol. 14, Iss. 1, pp. 672-687
Open Access | Times Cited: 5
Single-cell mapping reveals several immune subsets associated with liver metastasis of pancreatic ductal adenocarcinoma
Ze Zhang, Xiaoqiang Zhu, Feng Yang, et al.
Med (2023) Vol. 4, Iss. 10, pp. 728-743.e7
Closed Access | Times Cited: 4
Ze Zhang, Xiaoqiang Zhu, Feng Yang, et al.
Med (2023) Vol. 4, Iss. 10, pp. 728-743.e7
Closed Access | Times Cited: 4
Caffeic acid, a dietary polyphenol, pre-sensitizes pancreatic ductal adenocarcinoma to chemotherapeutic drug
Shruti Gupta, Harshita Tak, Khushhal Rathore, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-15
Closed Access | Times Cited: 1
Shruti Gupta, Harshita Tak, Khushhal Rathore, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-15
Closed Access | Times Cited: 1
Brusatol increases chemotherapeutic drug efficacy in pancreatic ductal adenocarcinoma by suppressing Nrf2 signaling
Juan Zhang, Hong‐Xi Xu, Yulin Wu, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 1
Juan Zhang, Hong‐Xi Xu, Yulin Wu, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 1
Pentapeptide PYRAE triggers ER stress-mediated apoptosis of breast cancer cells in mice by targeting RHBDF1-BiP interaction
SungJu Ryu, Hui Long, Xin-ling Zheng, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 2, pp. 378-390
Closed Access | Times Cited: 2
SungJu Ryu, Hui Long, Xin-ling Zheng, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 2, pp. 378-390
Closed Access | Times Cited: 2
Neoadjuvant treatment of pancreatic ductal adenocarcinoma: Whom, when and how
Nebojša Manojlović, Goran Savić, Stevan Manojlovic
World Journal of Gastrointestinal Surgery (2024) Vol. 16, Iss. 5, pp. 1223-1230
Open Access
Nebojša Manojlović, Goran Savić, Stevan Manojlovic
World Journal of Gastrointestinal Surgery (2024) Vol. 16, Iss. 5, pp. 1223-1230
Open Access
Unraveling the interplay: exploring signaling pathways in pancreatic cancer in the context of pancreatic embryogenesis
Sashikanta Swain, Ravi Kant Narayan, P Mishra
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Sashikanta Swain, Ravi Kant Narayan, P Mishra
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Spatial Organization of Chromatin of the KLF5 Gene Promoter Region in Pancreatic Ductal Adenocarcinoma Cells
M. V. Zinovyeva, Л. Г. Николаев
Molecular Biology (2024) Vol. 58, Iss. 5, pp. 881-895
Closed Access
M. V. Zinovyeva, Л. Г. Николаев
Molecular Biology (2024) Vol. 58, Iss. 5, pp. 881-895
Closed Access
Identification and validation the predictive biomarkers based on risk-adjusted control chart in gemcitabine with or without erlotinib for pancreatic cancer therapy
Aijun Zhao, Dongsheng Tu, Ye He, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Aijun Zhao, Dongsheng Tu, Ye He, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Exploring the value of multiparametric quantitative MRI in the assessment of pancreatic ductal adenocarcinoma fibrosis grading
Fangqing Wang, Xinghua Xu, Jianwei Xu, et al.
European Radiology (2024)
Closed Access
Fangqing Wang, Xinghua Xu, Jianwei Xu, et al.
European Radiology (2024)
Closed Access
Molecular and cellular mechanisms of PDAC progression based on RETN-CAP1-mediated macrophage-fibroblast crosstalk: Action of ITGB5 and ITGB1 recombinant proteins
Guangquan Zhang, Xiaozhun Huang, Ruixi Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 290, pp. 139078-139078
Closed Access
Guangquan Zhang, Xiaozhun Huang, Ruixi Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 290, pp. 139078-139078
Closed Access
Caffeic acid, a dietary polyphenol pre-sensitizes PDAC to chemotherapeutic drug
Shruti Gupta, Harshita Tak, Khushhal Rathore, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Shruti Gupta, Harshita Tak, Khushhal Rathore, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Novel Pyrazolopyrazine Compounds as SHP2 Inhibitors for Treating Glioblastoma
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 10, pp. 1336-1337
Open Access | Times Cited: 1
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 10, pp. 1336-1337
Open Access | Times Cited: 1
Epigenetic Alterations in Pancreatic Cancer
Cincin Zeynep Bulbul, Bulbul Muhammed Volkan, Sahin Soner
Epigenetics and human health (2023), pp. 275-294
Closed Access
Cincin Zeynep Bulbul, Bulbul Muhammed Volkan, Sahin Soner
Epigenetics and human health (2023), pp. 275-294
Closed Access
Molecular underpinnings of pancreatic cancer: Innovations in treatment and future perspectives
Mesut Tez, Eda Şahingöz, Fahri Martlı
Gastrointestinal Tract (2023) Vol. 1
Open Access
Mesut Tez, Eda Şahingöz, Fahri Martlı
Gastrointestinal Tract (2023) Vol. 1
Open Access
